mChIP-seq for Multiplex and Multifactorial Epigenomic Profiling Uncovers Cancer-specific Histone Features in Cellular...

Area of Science:

• Epigenetics
• Molecular Biology
• Genomics

Background:

• Histone modifications play crucial roles in gene regulation within specific cell types.
• Investigating these roles is key for developing noninvasive epigenetic biomarkers.
• Cell-free nucleosomes offer a promising source for such biomarkers.

Purpose of the Study:

• To introduce mChIP-seq, a novel epigenomic profiling technology.
• To enable simultaneous profiling of multiple histone modifications in both cellular and cell-free samples.
• To enhance efficiency and reduce costs associated with epigenomic analysis.

Main Methods:

• Developed mChIP-seq, integrating sample indexing and a pool-and-split immunoprecipitation strategy.
• Applied mChIP-seq to profile H2A.Z and 10 histone modifications in 9 cancer cell lines.
• Created cf-mChIP-seq, a method for profiling circulating nucleosomes from plasma samples.

Main Results:

• mChIP-seq demonstrated high efficiency and cost-effectiveness for large-scale epigenomic profiling.
• Identified an atypical association between H2A.Z and H3K4me3 at cancer promoter regions.
• cf-mChIP-seq detected distinct cfDNA fragment patterns in breast cancer patients versus healthy controls, using minimal plasma volume.

Conclusions:

• mChIP-seq is a versatile technology for comprehensive epigenomic profiling of nucleosomes.
• cf-mChIP-seq shows significant potential for advancing liquid biopsy techniques.
• Epigenomic profiling of cell-free nucleosomes can reveal cancer-specific patterns.